文献速递前列腺增生与排尿功能障碍泌尿系感染

自我管理神经调控减少脊髓损伤患者膀胱过度活动症药物:一项随机试验

Reduction of Overactive Bladder Medications in Spinal Cord Injury With Self-Administered Neuromodulation: A Randomized Trial.
PubMed 文献 · J Urol · 2024-08-02

该3个月随机、研究者盲法试验在42例完成试验的脊髓损伤间歇导尿患者中比较经皮胫神经刺激与假刺激,结果显示胫神经刺激组减少膀胱药物的比例显著高于对照组(95% vs 68%),差异26.2%(95%CI 1.17%-51.2%),两组功能和生存质量问卷及膀胱测压参数无显著差异。作者认为经皮胫神经刺激可作为减少或替代膀胱过度活动症药物的选择。

要点

  • 胫神经刺激组95%患者减少膀胱药物,对照组68%,差异26.2%(95%CI 1.17%-51.2%)
  • 试验结束时两组功能、生存质量问卷及膀胱测压参数无显著差异
  • 胫神经刺激满意度问卷及方案依从性均高

核心结论

  • 在慢性脊髓损伤行间歇导尿的患者中,经皮胫神经刺激可作为减少或替代膀胱过度活动症药物的一种选择。

研究设计与样本

  • 3个月、随机、研究者盲法的胫神经刺激与假刺激对照试验。
  • 纳入50例脊髓损伤伴神经源性膀胱、行间歇导尿并服用膀胱过度活动症药物的成人,42例完成试验。

主要发现

  • 试验结束时胫神经刺激组减少药物的比例显著高于对照组(95% vs 68%),药物减少差异为26.2%(95%CI 1.17%-51.2%)。
  • 试验结束时两组功能问卷、生存质量问卷及膀胱测压参数相似。
  • 胫神经刺激满意度问卷和方案依从性均高。
  • 无因刺激问题导致的脱落。

关键数值与推荐

  • 主要结局为减少膀胱药物的同时,基于神经源性膀胱症状评分和失禁生存质量问卷分别维持稳定的膀胱症状和生存质量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our goal was to evaluate if self-administered bladder neuromodulation with transcutaneous tibial nerve stimulation could safely replace overactive bladder medications in people with spinal cord injury. MATERIALS AND METHODS: We performed a 3-month, randomized, investigator-blinded, tibial nerve stimulation vs sham-control trial in adults with spinal cord injury and neurogenic bladder performing intermittent catheterization and taking overactive bladder medications. The primary outcome was a reduction in bladder medications while maintaining stable bladder symptoms and quality of life based on pre/post Neurogenic Bladder Symptom Score and the Incontinence Quality of Life questionnaire, respectively. Secondary outcomes included changes in pre/post cystometrogram, 2-day voiding diaries, and an anticholinergic medication side effect survey. RESULTS: Fifty people consented to the study, with 42 completing the trial. No dropouts were due to stimulation issues. All baseline demographics and surveys were comparable at baseline. Cystometrogram parameters were also comparable at baseline, except the stimulation group had a higher proportion of loss of bladder compliance compared to the control group. At the end of the trial, a significantly greater percentage of the tibial nerve stimulation group was able to reduce medications (95% vs 68%), by a 26.2% difference in medication reduction (95% CI 1.17%-51.2%). Function and quality of life surveys and cystometrograms at the end of the trial were alike between groups. Transcutaneous tibial nerve stimulation satisfaction surveys and adherence to protocol were high. CONCLUSIONS: In people with chronic spinal cord injury performing intermittent catheterization, transcutaneous tibial nerve stimulation can be an option to reduce or replace overactive bladder medications.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Stampas A, Korupolu R, Lee KH, et al. Reduction of Overactive Bladder Medications in Spinal Cord Injury With Self-Administered Neuromodulation: A Randomized Trial. J Urol. 2024. PMID: 39093916. doi:10.1097/JU.0000000000004189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。